In T1D, adenosine plays a central role in executing the nephroprotective response of SGLT2 inhibitors, by ameliorating preglomerular arteriolar dilation and hyperfiltration via the adenosine receptor A1R, acting on the vasoconstriction of afferent arterioles. The gene discussed is SLC5A2; the disease is type 1 diabetes mellitus.